<VariationArchive VariationID="627273" VariationName="NM_000419.5(ITGA2B):c.2148dup (p.Leu717fs)" VariationType="Duplication" Accession="VCV000627273" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-14" DateCreated="2019-09-29" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="615574" VariationID="627273">
      <GeneList>
        <Gene Symbol="ITGA2B" FullName="integrin subunit alpha 2b" GeneID="3674" HGNC_ID="HGNC:6138" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44372181" stop="44389649" display_start="44372181" display_stop="44389649" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42449549" stop="42466872" display_start="42449549" display_stop="42466872" Strand="-" />
          </Location>
          <OMIM>607759</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000419.5(ITGA2B):c.2148dup (p.Leu717fs)</Name>
      <CanonicalSPDI>NC_000017.11:44377736:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44377736" stop="44377737" display_start="44377736" display_stop="44377737" variantLength="1" positionVCF="44377736" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42455104" stop="42455105" display_start="42455104" display_stop="42455105" variantLength="1" positionVCF="42455104" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>L717fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_479t1" sequenceAccession="LRG_479t1" change="c.2148dup">
            <Expression>LRG_479t1:c.2148dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_479" sequenceAccession="LRG_479" change="g.16769dup">
            <Expression>LRG_479:g.16769dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.5" sequenceAccession="NM_000419" sequenceVersion="5" change="c.2148dup" MANESelect="true">
            <Expression>NM_000419.5(ITGA2B):c.2148dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42455105dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42455105dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44377737dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44377737dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008331.1" sequenceAccession="NG_008331" sequenceVersion="1" change="g.16769dup">
            <Expression>NG_008331.1:g.16769dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.5" sequenceAccession="NM_000419" sequenceVersion="5" change="c.2148dup" MANESelect="true">
            <Expression>NM_000419.5:c.2148dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000410.2" sequenceAccession="NP_000410" sequenceVersion="2" change="p.Leu717fs">
            <Expression>NP_000410.2:p.Leu717fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.3" sequenceAccession="NM_000419" sequenceVersion="3" change="c.2148dupG">
            <Expression>NM_000419.3:c.2148dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1598377980" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000419.5(ITGA2B):c.2148dup (p.Leu717fs) AND Macrothrombocytopenia" Accession="RCV000852070" Version="1">
        <ClassifiedConditionList TraitSetID="46893">
          <ClassifiedCondition DB="MedGen" ID="C2751260">Macrothrombocytopenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000419.5(ITGA2B):c.2148dup (p.Leu717fs) AND Glanzmann thrombasthenia" Accession="RCV001044708" Version="6">
        <ClassifiedConditionList TraitSetID="734">
          <ClassifiedCondition DB="MedGen" ID="C0040015">Glanzmann thrombasthenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2020-12-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-12-09" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-09-29" MostRecentSubmission="2024-02-14">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21917754</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25728920</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/186c1bc8-d67e-4eab-86d6-4c930b1470dc</URL>
        </Citation>
        <DescriptionHistory Dated="2021-08-26">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="46893" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="34252" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Macrothrombocytopenia</ElementValue>
                <XRef ID="HP:0040185" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C2751260" DB="MedGen" />
              <XRef Type="primary" ID="HP:0040185" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3893" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann's thrombasthenia</ElementValue>
                <XRef ID="Thrombasthenia+of+Glanzmann+and+Naegeli/7074" DB="Genetic Alliance" />
                <XRef ID="32942005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia</ElementValue>
                <XRef ID="MONDO:0100326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann thrombasthenia type A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diacyclothrombopathia 2B 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia of Glanzmann and Naegeli</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2478" />
                <XRef ID="2478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="849" DB="Orphanet" />
              <XRef ID="C0040015" DB="MedGen" />
              <XRef ID="MONDO:0100326" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS273800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1769620" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.2148dupG_HP:0040185" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899595" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0122</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000419.3:c.2148dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0040185" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="3550727" SubmissionDate="2021-08-25" DateLastUpdated="2021-08-27" DateCreated="2021-08-27">
        <ClinVarSubmissionID localKey="186c1bc8-d67e-4eab-86d6-4c930b1470dc" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001809925" DateUpdated="2021-08-27" DateCreated="2021-08-27" Type="SCV" Version="1" SubmitterName="ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen" OrgID="507662" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-09">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/186c1bc8-d67e-4eab-86d6-4c930b1470dc</URL>
          </Citation>
          <Comment>The p.Leu717fsTer3 variant on ITGA2B is a frameshift variant located on exon 21,which is predicted to introduce a premature stop codon leading to nonsense medicated decay and loss of protein function. This variant has been reported in at least one proband in a homozygous state who meets criteria for the GT phenotype. This variant is absent from all large population databases. In summary, p.Leu717fs*3 variant meets criteria for PVS1, PP4_strong, PM3_supporting and PM2_supporting and is classified as Pathogenic for GT.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Platelet ACMG Specifications v2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/r2stlucp/clingen_platelet_acmg_specifications_v2.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000419.5(ITGA2B):c.2148dup</Name>
            <Name>p.Leu717fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.44377737dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100326" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10236687</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2373801" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4943083|MedGen:C0040015" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001208519" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21917754</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25728920</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ITGA2B are known to be pathogenic (PMID: 21917754). This variant has been observed in individual(s) with autosomal recessive Glanzmann thrombasthenia (PMID: 25728920). ClinVar contains an entry for this variant (Variation ID: 627273). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu717Alafs*3) in the ITGA2B gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.42455104_42455105insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0040015" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3550727" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100326" MappingRef="MONDO">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769620" TraitType="Finding" MappingType="XRef" MappingValue="HP:0040185" MappingRef="HP">
        <MedGen CUI="C2751260" Name="Macrothrombocytopenia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2373801" TraitType="Disease" MappingType="XRef" MappingValue="C0040015" MappingRef="MedGen">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

